Company News

Lonza Buys Capsugel

$5.5 billion deal announced with KKR.

Author Image

By: Christine Esposito

Editor-in-Chief

Lonza Group AG has entered into a definitive agreement to acquire Capsugel from KKR for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion. The acquisition—designed to create a leading integrated, value-added solutions provider in drug development, formulation, delivery technologies and manufacturing— is fully in line with Lonza's stated strategy to accelerate growth and deliver value along the healthcare continuum by complementing its existing...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters